| Literature DB >> 35502075 |
Rasha M Eltanamly1, Hany Elmekawey1, Maha M Youssef1, Lameece M Hassan1.
Abstract
Purpose: Phacoemulsification surgery requires the use of both hands; however, some surgeons may not be comfortable using their non-dominant hand, especially in critical steps such as chopping. This work aims at assessing whether a virtual reality simulator can help cataract surgeons train their non-dominant hand using the capsulorhexis module.Entities:
Keywords: Capsulorhexis; non-dominant hand; simulator training
Mesh:
Year: 2022 PMID: 35502075 PMCID: PMC9333039 DOI: 10.4103/ijo.IJO_2652_21
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 2.969
Figure 1(a) Experienced surgeon performing capsulorrhexis with their dominant hand (b) Same surgeon performing the same procedure with their non dominant hand (c) Screen shot showing test score of an experienced surgeon in the third trial of his non-dominant hand. (d) Screen showing animated image of capuslorrhexis module (e) The Eyesi surgical simulator (head piece, binocular microscope, foot pedal and screen to monitor the trainee)
Comparison between intermediate and experienced surgeons as regards mean global test score in six trials
| Trial | Rank of surgeon |
| |||
|---|---|---|---|---|---|
|
| |||||
| Experienced | Intermediate | ||||
|
|
| ||||
| Mean | SD | Mean | SD | ||
| D1a | 85.65 | 7.75 | 81.57 | 7.04 | 0.224 |
| D2b | 86.87 | 6.70 | 84.14 | 5.90 | 0.342 |
| D3c | 88.70 | 7.73 | 83.71 | 6.02 | 0.130 |
| ND1d | 72.96 | 17.39 | 58.43 | 20.78 | 0.130 |
| ND2e | 78.48 | 12.63 | 60.71 | 27.65 | 0.022 |
| ND3f | 86.17 | 8.97 | 81.00 | 9.49 | 0.198 |
aD1: first trial with dominant hand, bD2: second trial with dominant hand, cD3: third trial with dominant hand, dND1: first trial with non-dominant hand, eND2: second trial with non-dominant hand, fND3: third trial with non-dominant hand
Mean of global test score of dominant and non-dominant hands
| Trial | Mean | Standard Deviation |
| |
|---|---|---|---|---|
| D1a | 84.70 | 7.68 | 0.119 | ---- |
| D2b | 86.23 | 6.53 | 0.657 | |
| D3c | 87.53 | 7.57 | 1 | |
| ND1d | 69.57 | 18.92 | <0.001 | ---- |
| ND2e | 74.33 | 18.38 | 0.589 | |
| ND3f | 84.97 | 9.20 | 0.001 |
aD1: first trial with dominant hand, bD2: second trial with dominant hand, cD3: third trial with dominant hand, dND1: first trial with non-dominant hand, eND2: second trial with non-dominant hand, fND3: third trial with non-dominant hand